Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002315342 | SCV000849135 | likely benign | Inborn genetic diseases | 2016-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000961628 | SCV001108679 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000961628 | SCV001501692 | likely benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000961628 | SCV005209560 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003953273 | SCV004769634 | benign | CC2D1A-related disorder | 2020-01-13 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |